Found 4 matching trials
Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor) PHASE1 The PROCEADE PanTumor study aims to investigate M9140 in multiple tumor typ...
Show More Status
Active Not Recruiting
Location
University of California - Los Angeles - 300208353
Learn More & Join Trial
Anti-CEACAM5 ADC Precemtabart Tocentecan (M9140) in Chinese Participants With Solid Tumors PHASE1 The purpose of this study is to evaluate the safety and early clinical acti...
Show More Status
Active Not Recruiting
Location
Beijing Cancer Hospital
Learn More & Join Trial
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03) PHASE3 This study aims to address the unmet medical need of participants with meta...
Show More Location
Rocky Mountain Cancer Centers, LLP- Aurora
Learn More & Join Trial
Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01) PHASE1 The purpose of this first in-human study is to evaluate the safety, tolerab...
Show More Status
Active Not Recruiting
Location
California Cancer Associates for Research & Excellence, Inc.
Learn More & Join Trial